1Anderson S,Jung FF,Ingelfinger JR.Renal renin-angiotensin system in diabetes:functional,immunohistochemical,and molecular biological correlations[J].Am J Physiol,1993,265(4 Pt 2):F477-F486.
2Kikkawa R,Kitamura E,Fujiwara Y,et al.Biphasic alteration of renin-angiotensin-aldosterone system in streptozotocin-diabetic rats[J].Ren Physiol,1986,9(3):187-92.
3Touyz RM.Molecular and cellular mechanisms in vascular injury in hypertension:role of angiotensin Ⅱ[J].Curr Opin Nephrol Hypertens,2005,14(2):125-131.
4Wolf G,Ziyadeh FN.The role of angiotensin Ⅱ in diabetic nephropathy:emphasis on nonhemodynamic mechanisms[J].Am J Kidney Dis,1997,29(1):153-163.
5Leehey DJ,Singh AK,Alavi N,et al.Role of angiotensin Ⅱ in diabetic nephropathy[J].Kidney Int Suppl,2000,77:S93-S98.
6Wolf G,Haberstroh U,Neilson EG.Angiotensin Ⅱ stimulates the proliferation and biosynthesis of type Ⅰ collagen in cultured murine mesangial cells[J].Am J Pathol,1992,140(1):95-107.
7Huang XR,Chen WY,Truong LD,et al.Chymase is upregulated in diabetic nephropathy:implications for an alternative pathway of angiotensin Ⅱ-mediated diabetic renal and vascular disease[J].J Am Soc Nephrol,2003,14(7):1738-1747;Comment in:1952-1954.
8Mogensen CE,Neldam S,Tikkanen I,et al.Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension,microalbuminuria,and non-insulin dependent diabetes:the candesartan and lisinopril microalbuminuria(CALM)study.BMJ,2000,321:1440-1444.
9Cao Z,Bonnet F,Candido R,et al.Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury[J].J Am Soc Nephrol,2002,13(7):1773-1787.
10Komine N,Khang S,Wead LM,et al.Effect of combining an ACE inhibitor and an angiotensin Ⅱ receptor blocker on plasma and kidney tissue angiotensin Ⅱ levels[J].Am J Kidney Dis,2002,39(1):159-164.
8Viswanathan V,Snehalatha C, Nair MB, et al. Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects[J]. Diabetes Metab Res Rev, 2005,21 (3) :276-280.
9Isono M, Chen S, Hong SW, et al. Smad pathway is activated in the diabetic mouse kindey and Smad3 mediated TGF-beta-induced fibronection in mesangial cells [J]. Biochem Biophys Res Commun, 2002, 296(5): 1356-65.
10Wolf G, Ziyadeh FN, Noble NA. Transforming growth factor-β and diabetic nephropathy[J]. Organ Dys, 2009, 5(3): 130-9.
